Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Nuance Communications To Buy QuadraMed's Health Information Management Business

RELATED NEWS
Trade NUAN now with 

Nuance Communications Inc. (NUAN: Quote) said it would acquire Quantim, the Health Information Management or HIM business of QuadraMed Corp. (QDHC: Quote), an information technology solutions provider for the healthcare industry. On working closely with industry partners, Nuance and Quantim would ease healthcare providers' transition to ICD-10, while preserving clinician productivity and document workflows and, most importantly, ensuring the quality of patient care.

The company noted that this accretive transaction would integrate Nuance clinical language understanding or CLU and Quantim Coding Solutions to enhance productivity and ensure accurate reimbursement for healthcare providers.

Nuance plans to deliver CLU-powered CAC solutions quickly into the market within Quantim's integrated, web-based platform to support a more efficient transition to ICD-10 and deliver better financial results for customers.

Click here to receive FREE breaking news email alerts for Nuance Communications, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.